Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Ukraine

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Ukraine Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20071
20081
20091
20111
20131
20161
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amarin Pharma Inc.2
Amgen2
Takeda2
Boehringer Ingelheim1
Institut de Recherches Internationales Servier1
Kowa Research Institute, Inc.1
Solvay Pharmaceuticals1
Tanabe Pharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias11
Glucose Metabolism Disorders3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Hypercholesterolemia2
Hypertension2
Hypertriglyceridemia2
Acute Coronary Syndrome1
Angina Pectoris1
Arterial Occlusive Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.